Advanced Drug Delivery Reviews

Papers
(The H4-Index of Advanced Drug Delivery Reviews is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Liposome composition in drug delivery design, synthesis, characterization, and clinical application315
COVID-19 vaccines: The status and perspectives in delivery points of view247
Self-assembled mRNA vaccines243
The role of lipid components in lipid nanoparticles for vaccines and gene therapy196
Supramolecular engineering of hydrogels for drug delivery167
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives163
Pharmaceutical electrospinning and 3D printing scaffold design for bone regeneration161
Overcoming barriers by local drug delivery with liposomes156
Non-viral COVID-19 vaccine delivery systems154
DNA hydrogel-based gene editing and drug delivery systems153
Recombinant protein vaccines, a proven approach against coronavirus pandemics153
Translating 3D printed pharmaceuticals: From hype to real-world clinical applications147
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers133
Dosing extracellular vesicles129
Peptide and peptide-based inhibitors of SARS-CoV-2 entry126
Frontiers in the treatment of glioblastoma: Past, present and emerging124
Nucleic acid delivery for therapeutic applications122
RNAi-based therapeutics and tumor targeted delivery in cancer122
Fibronectin in development and wound healing121
Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation120
Advances in powder bed fusion 3D printing in drug delivery and healthcare117
Rational designs of in vivo CRISPR-Cas delivery systems116
Connected healthcare: Improving patient care using digital health technologies115
Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites109
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy108
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis108
Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery106
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment104
Machine learning directed drug formulation development99
Cardiac fibrosis: Myofibroblast-mediated pathological regulation and drug delivery strategies96
Antimicrobial peptides towards clinical application: Delivery and formulation93
Peptide-based supramolecular hydrogels for local drug delivery92
Clinical translation of nanomedicines: Challenges, opportunities, and keys92
Targeting drug delivery with light: A highly focused approach92
(Macro)molecular self-assembly for hydrogel drug delivery91
Engineering the drug carrier biointerface to overcome biological barriers to drug delivery90
Nanoscale MOFs: From synthesis to drug delivery and theranostics applications89
Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies88
Polymeric drug delivery systems by additive manufacturing87
Approaches to surface engineering of extracellular vesicles87
Topical drug delivery: History, percutaneous absorption, and product development85
Harnessing artificial intelligence for the next generation of 3D printed medicines84
Near-infrared fluorescence imaging in immunotherapy84
Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities84
Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network83
Emerging 3D printing technologies for drug delivery devices: Current status and future perspective82
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment82
Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases82
Technology insight: Plant-derived vesicles—How far from the clinical biotherapeutics and therapeutic drug carriers?81
Challenges of fused deposition modeling 3D printing in pharmaceutical applications: Where are we now?80
Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants78
Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis78
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge77
Microneedle-Mediated Vaccination: Innovation and Translation76
Let’s talk about sex: Differences in drug therapy in males and females73
Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance73
Clinically established biodegradable long acting injectables: An industry perspective73
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?72
The effects of protein corona on in vivo fate of nanocarriers72
An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers71
Target specific tight junction modulators71
Advances in gene-based vaccine platforms to address the COVID-19 pandemic71
Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health71
Biomedical engineering of two-dimensional MXenes70
Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic69
Nanocarrier vaccines for SARS-CoV-269
Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug delivery67
Why nanoparticles prefer liver macrophage cell uptake in vivo67
Photodynamic and antibiotic therapy in combination against bacterial infections: efficacy, determinants, mechanisms, and future perspectives67
0.024118185043335